Arizona Bioscience News: UArizona spinoffs advance; Seres Therapeutics seeks healthy stool; New omicron variant in Arizona

March 17, 2022

By brianpowell

UA battery tech, diagnostic tech spinoffs advance / Arizona Daily Star

University of Arizona tech spinoffs advancing new battery and medical diagnostic technologies have taken important steps toward taking their inventions to market.

Get paid up to $1,200 a month for your poop by Tempe biotech company / Arizona Republic

Seres Therapeutics, a Massachusetts biotech company expanding into Tempe, is developing a treatment for reducing recurrent Clostridium difficile infection that requires a steady supply of healthy human stool.

Pfizer’s COVID vaccine less effective at preventing infection in younger children, new study finds / KTAR

University of Arizona Health Sciences researchers contributed to an ongoing Centers for Disease Control and Prevention study that shows the Pfizer-BioNTech COVID-19 vaccine is less effective at reducing the risk of infection among younger children compared to older age groups.

New omicron variant has made its way to Arizona / KOLD

The new COVID-19 omicron variant called BA.2, a subvariant of the original omicron, is responsible for about 10% of the new cases in Arizona, according to Translational Genomics Research Institute.

Arizona’s startup founders of color, women get far less funding from investors, data shows / Phoenix Business Journal

A Phoenix Business Journal analysis shows that in Arizona, most of the largest venture capital deals during 2021 went to companies run by white men and none went to companies with female leaders.

Tuba City cancer care program receives $8 million in federal funding / KNAU

A new federal bill includes $8 million for the cancer treatment center at the Tuba City Regional Health Care Corporation, funding that will help develop long-term care and skilled nursing services for Navajo elders.

Competition gets fierce in AZ Inno Madness. Time to vote in Round Three / Phoenix Business Journal (AZ Inno)

In the AZ Inno Madness bracket that started with 16 Phoenix-area startups, Humabiologics will face off against Lunewave and qBotica will take on YellowBird to see who advances to the championship matchup.

2 years of COVID-19: 15 pivotal moments during Arizona’s pandemic / Arizona Republic

It’s been nearly two years since Arizona Gov. Doug Ducey issued a stay-at-home pandemic order that, for most people, instantly halted regular daily life.

Upcoming Events

March 25: Arizona BioPreneur Conference

April 4-6: Tucson Symposium 2022

Sign up to receive Arizona Bioscience News weekly

Search the Arizona BioMap